RS enters the final week of June with an unusual split: the stock fell 3.6% on the week to $398.63, yet that mild retreat looks almost defensive next to the carnage across its peer group.
The sector context is stark. Close peers NUE and STLD dropped 7.6% and 10.5% respectively over the same period. CLF fell more than 18%. Against that backdrop, Reliance's week reads less like weakness and more like an orderly pullback in a sector-wide sell-off — the company's diversified distribution model continuing to do what it's designed to do, absorb volatility better than integrated steel producers exposed to spot price swings.
Options traders are the most bullish they've been in months, and that makes the positioning story worth unpacking. The put/call ratio dropped to 0.29 this week — nearly three standard deviations below its 20-day average of 0.42, and approaching the 52-week low of 0.18. That is an unusually one-sided call-heavy setup. Whether that reflects genuine conviction or simply a lack of hedging demand into the Q2 print on July 23 is the open question. Short interest is not adding much signal: at 1.5% of free float, it's low and roughly flat on the week (-0.4%). Borrowing costs have eased to around 0.37%, down about 8% week-on-week, with availability running at more than 4,500% — the lending market is entirely uncongested. There is no short-side pressure here.
The Street's direction of travel has been unambiguously upward on price targets, even where conviction on the rating itself has stayed cautious. KeyBanc lifted its target to $418 from $378 just this week, maintaining its Overweight. JP Morgan raised to $378 from $345 two weeks ago while holding at Neutral. Wells Fargo moved to $376 from $343. The pattern: analysts are chasing the stock higher on targets while stopping short of committing to outright bullish ratings — mean target sits at $377.57, fractionally below the current price of $398.63, which suggests the Street has been running behind the tape since the stock's 8.6% one-month gain. Valuation multiples reflect that: PE has expanded roughly 1.1 turns over the past 30 days to 19.4x, while EV/EBITDA has drifted slightly lower to 12.7x. Factor scores are broadly constructive — dividend commitment ranks in the 99th percentile, EPS surprise in the 72nd, and the short score at 31 sits well into low-pressure territory.
Ownership is institutionally anchored, with BlackRock holding 11.4% and adding nearly 182,000 shares through May. T. Rowe Price added more than 576,000 shares over the same period — a meaningful incremental commitment from a name that typically moves with medium-term conviction. Insider activity from the past 90 days skews negative on a net-value basis, with the CFO selling around $1.25 million in late April, though these appear routine plan-related disposals rather than discretionary sales. The net share count for the period is positive after accounting for executive awards.
With Q2 results due July 23, the setup heading into that print is call-heavy options, compressed short interest, recent analyst target upgrades that still trail the price, and a stock holding measurably better than its peer group in a soft tape — the key question is whether the distribution margin story on that print can justify a price that has now lapped consensus.
See the live data behind this article on ORTEX.
Open RS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
